Added to YB: 2026-01-29
Pitch date: 2026-01-27
LOVE.V [neutral]
Cannara Biotech Inc.
+5%
current return
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 183.9M
Pitch Price
CAD 1.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.53
P/E
16.11
EV/Sales
1.80
Sector
Personal Care Products
Category
growth
Cannara Biotech ($LOVE.V) FINS Review
LOVE.V (trimmed position): Q1 delivered 20th consecutive quarter of 20%+ YoY revenue growth to $30.1M, but net income fell 55% due to 340bp gross margin decline & SBC costs rising to $1.72M from $321K. Strong 2.7x current ratio, $8M op cash flow. Red flags: upcoming 15% SBC plan vote, more RSU vesting Q2. Downgraded to 3.5 stars.
Read full article (5 min)